BioCentury
ARTICLE | Clinical News

RP101: Phase II start

October 9, 2006 7:00 AM UTC

Early next year, AVTO will begin a double-blind, placebo-controlled Phase II trial comparing RP101 plus gemcitabine with gemcitabine alone ...